Precision Medicine Basket Trial Eligibility Across Race/Ethnicity: Implications for Ethnobridging and Clinical Application

Time

Wed, Jun 17 9:00AM
W 20

Title

Precision Medicine Basket Trial Eligibility Across Race/Ethnicity: Implications for Ethnobridging and Clinical Application

Abstract Summary

ORAL PRESENTATION SCHEDULED: Wednesday, June 17 in Session #2B at 12:17 - 12:22 pm in the Exhibit Hall Poster Area (Hall A entrance)

Patients within Moffitt’s Total Cancer Care (TCC) database with targeted tumor exome data available as of 2/6/2015 are described based on the presence of genetic alterations evaluated by FDA approved companion diagnostics in addition to variants included in basket trials open in North America.

Poster Presenter

Todd Knepper
PharmD,
Personalized Cancer Medicine Fellow ,
H. Lee Moffitt Cancer Center
United States